Section Arrow
Quote
ICCM.NASDAQ
- IceCure Medical Ltd
Quotes are at least 15-min delayed:2025/04/30 00:05 EDT
Last
 1.27
+0.05 (+4.10%)
Day High 
1.33 
Prev. Close
1.22 
1-M High
1.26 
Volume 
404.18K 
Bid
1.3
Ask
1.29
Day Low
1.2492 
Open
1.25 
1-M Low
1.05 
Market Cap 
71.51M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.15 
20-SMA 1.16 
50-SMA 1.27 
52-W High 1.66 
52-W Low 0.48 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.30/-0.07
Enterprise Value
71.67M
Balance Sheet
Book Value Per Share
0.12
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
3.29M
Operating Revenue Per Share
0.05
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed：2025/04/30 00:05 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.